AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Biotechnology company begins shipping influenza vaccine to Canadian customers.

Vaccine Weekly

| October 06, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 OCT 6 - (NewsRx.com & NewsRx.net) -- ID Biomedical Corporation (IDBE) has begun shipping its influenza vaccine, Fluviral S/F, to customers across Canada after receiving the required regulatory clearance from Health Canada.

This release will allow annual influenza vaccination programs with Fluviral to proceed as planned in all Canadian provinces and territories.

"We are very pleased with the timely release of Fluviral by the Canadian Health authorities. We have had a very good production season; our highly experienced team and state-of-the-art production facilities allowed us to ship influenza vaccine to the Canadian market ahead of schedule," said Richard Holslag, general manager, Quebec and Laval manufacturing sites.

"It will soon be available to health care professionals ...

Related articles from newspapers, magazines, journals, and more
ID Biomedical signs agreement to acquire vaccine business.
Newspaper article from: Vaccine Weekly May 19, 2004 700+ words
...NewsRx.net) -- ID Biomedical Corp. and Shire Pharmaceuticals...in the industry. ID Biomedical is positioned to become...being acquired by ID Biomedical from Shire include...article was prepared by Vaccine Weekly editors from staff...
ID Biomedical completes vaccine manufacturing facility; TRADING SYMBOLS -...
Press release article from: PR Newswire January 25, 2002 700+ words
VANCOUVER -- ID Biomedical Corporation announced today that...facility is located adjacent to ID Biomedical's research and development facility...Clinical Trials later this year. ID Biomedical's Chief Executive Officer, Anthony...
ID Biomedical Signs Agreement to Acquire Shire Pharmaceuticals' Vaccine...
Press release article from: PR Newswire April 20, 2004 700+ words
...Canada, April 20 /PRNewswire/ -- ID Biomedical Corporation and Shire Pharmaceuticals...sale of Shire's vaccine business to ID Biomedical. Closing of the transaction, which...terms of the agreement, upon closing, ID Biomedical will acquire all of Shire's vaccine...
ID Biomedical Completes Enrollment of 1,000 Subjects for Pivotal Fluviral...
Press release article from: PR Newswire March 30, 2005 700+ words
...March 30 /PRNewswire-FirstCall/ -- ID Biomedical Corporation (TSX: IDB; NASDAQ: IDBE...season," said Anthony Holler, M.D., ID Biomedical's Chief Executive Officer. ID Biomedical is also conducting a similar clinical...
ID Biomedical to pursue U.S. accelerated approval process for its influenza...
Press release article from: PR Newswire March 15, 2005 700+ words
...March 15 /PRNewswire-FirstCall/ -- ID Biomedical Corporation (TSX: IDB; NASDAQ...products addressing important needs. ID Biomedical and CBER have outlined a clinical trial...said Anthony Holler, M.D., ID Biomedical's Chief Executive Officer. "Obviously...
ID Biomedical develops vaccine manufacturing technology; TRADING SYMBOLS -...
Press release article from: PR Newswire March 10, 2003 700+ words
ID Biomedical announced today that it has developed...consistency in production have enabled ID Biomedical to transfer the technology to the...developed by Dynport Vaccine Corporation. ID Biomedical has filed U.S. and international...
ID Biomedical signs agreement to acquire Shire Pharmaceuticals' vaccine...
Press release article from: PR Newswire April 20, 2004 700+ words
ID Biomedical Corporation and Shire Pharmaceuticals...sale of Shire's vaccine business to ID Biomedical. Closing of the transaction, which...of the agreement, upon closing, ID Biomedical will acquire all of Shire's vaccine...
ID Biomedical establishes manufacturing group; TRADING SYMBOLS - NASDAQ -...
Press release article from: PR Newswire February 27, 2003 700+ words
ID Biomedical announced today that it has hired a team of senior...required for the eventual commercialization of ID Biomedical's products. To achieve these objectives, ID Biomedical has established a manufacturing group, which will...
ID Biomedical Provides Update on Vaccine Development Programs.
Press release article from: PR Newswire October 24, 2005 700+ words
...24 /PRNewswire-FirstCall/ -- ID Biomedical Corporation (TSX: IDB; NASDAQ...against group A streptococcal diseases. ID Biomedical announced that it has obtained clearance...studies in children. At this time, ID Biomedical is not able to precisely predict how...
ID Biomedical signs agreement to acquire Shire vaccine business.(ID Biomedical...
Newspaper article from: BIOTECH Patent News April 1, 2004 700+ words
ID Biomedical Corporation (Vancouver, Canada...sale of Shire's vaccine business to ID Biomedical. Closing of the transaction, which...of the agreement, upon closing, ID Biomedical will acquire all of Shire's vaccine...
For more facts and information, see all results

Source: HighBeam Research, Biotechnology company begins shipping influenza vaccine to Canadian...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA